Literature DB >> 19158822

Blood pressure variability and prevalence of hypertension using automated readings from multiple visits to a pharmacy-based community-wide programme.

T Karwalajtys1, J Kaczorowski, B Hutchison, M G Myers, S M Sullivan, L W Chambers, L Lohfeld.   

Abstract

Blood pressure (BP) measurements taken outside the routine office context may be a useful adjunct strategy to monitor BP. Community-based BP data can also provide estimates of the prevalence of elevated BP. We compared multiple readings taken on different days in pharmacies using an automated BpTRU device during a cardiovascular health programme targeting community-dwelling older adults. Mean systolic (S) and diastolic (D) BP values were compared over time using repeated measures analysis of variance for all participants with at least three separate sets of readings (n=317). BP variability was then examined among four subgroups based on report of antihypertensive medication or no treatment, and normal or elevated SBP at the initial visit (< or >or=140, or 130 if diabetes reported). Prevalence of elevated BP was compared across visits. Overall, mean SBP decreased between visits 1 and 2 (140.4 vs 137.1 mm Hg; P<0.001). Among participants with normal SBP at the initial visit, SBP did not vary significantly, whether or not antihypertensive treatment was reported. Those with initially elevated SBP experienced a significant decrease between visits 1 and 2, also regardless of treatment status. Prevalence of elevated BP decreased from visits 1 to 2 (55.8 vs 48.9%; P=0.026) and from visits 1 to 3 (55.8 vs 42.9%; P<0.001). Analyses of BP data from a community-based programme using an accurate device showed that initial readings may inflate the population estimate of elevated BP. Findings suggest that more than one set of BP readings measured on different occasions are needed, particularly if the first set is elevated.

Entities:  

Mesh:

Year:  2009        PMID: 19158822     DOI: 10.1038/jhh.2008.163

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  6 in total

Review 1.  Clinical value of blood pressure measurement in the community pharmacy.

Authors:  Daniel Sabater-Hernández; Inés Azpilicueta; Pablo Sánchez-Villegas; Pedro Amariles; María I Baena; María J Faus
Journal:  Pharm World Sci       Date:  2010-07-23

2.  Burden, patterns, and impact of multimorbidity in North India: findings from a rural population-based study.

Authors:  Priti Gupta; Shivani A Patel; Hanspria Sharma; Prashant Jarhyan; Rakshit Sharma; Dorairaj Prabhakaran; Nikhil Tandon; Sailesh Mohan
Journal:  BMC Public Health       Date:  2022-06-02       Impact factor: 4.135

3.  Hypertension management initiative prospective cohort study: comparison between immediate and delayed intervention groups.

Authors:  S W Tobe; M Moy Lum-Kwong; S Von Sychowski; K Kandukur; A Kiss; V Flintoft
Journal:  J Hum Hypertens       Date:  2013-06-13       Impact factor: 3.012

4.  Agreement between community pharmacy and ambulatory and home blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study.

Authors:  Daniel Sabater-Hernández; Alejandro De La Sierra; Pablo Sánchez-Villegas; Fidelina M Santana-Pérez; Luisa Merino-Barber; María J Faus
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-05       Impact factor: 3.738

5.  Community pharmacy interventions for health promotion: effects on professional practice and health outcomes.

Authors:  Liz Steed; Ratna Sohanpal; Adam Todd; Vichithranie W Madurasinghe; Carol Rivas; Elizabeth A Edwards; Carolyn D Summerbell; Stephanie Jc Taylor; R T Walton
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

6.  The effectiveness of screening for diabetes and cardiovascular disease risk factors in a community pharmacy setting.

Authors:  Andrew Willis; Peter Rivers; Laura J Gray; Melanie Davies; Kamlesh Khunti
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.